Hematology Analyzer For Research Articles & Analysis
7 news found
Results from the study were featured in a poster presentation as Abstract 2171 at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition on December 10, 2022 and have been published online at Blood®. ...
Guido Marcucci, MD, Chair and Professor, Department of Hematologic Malignancies Translational Science; Director, Gehr Family Center for Leukemia Research, and Chief of Leukemia Division within the Department of Hematology & Hematopoietic Cell Transplantation, City of Hope; and Principal Investigator for the myCare-023 clinical trial. ...
Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology, announced that the company is expanding its scientific advisory board with the appointment of Jeff Sharman, M.D. and Clive Stanway, Ph.D. These two leaders in the field of cancer therapeutics will provide expert support and guidance as Araris continues preclinical and clinical development of its ...
The latest call for proposals aims to provide funding for clinical research programs that leverage NGS in solid tumors and hematology-oncology applications. ...
The HemoScreen will be a key piece of research equipment in our cohort study." RURAL plans to deploy HemoScreen hematology analyzers within the MEU lab to do phenotypic measurements in a non-clinical research setting in the rural south, and to test the performance characteristics of the HemoScreen in this setting. ...
In hematology oncology, it is critically important to understand the genetics driving acute malignancies to quickly determine how best to address the disease. ...
Clinical researchers who take a traditional sequential approach to analyze myeloid malignancies, a highly heterogeneous group of disorders, face a major hurdle: a laborious and time-consuming workflow. ...